Released on: September 26, 2008, 10:10 am

Press Release Author: Medical Technology Association of Australia

Industry: Healthcare

Press Release Summary: Masimo wins 2008 Kerrin Rennie Award for Medical Excellence

Press Release Body: Sydney, Australia-September 25, 2008--
A non-invasive blood monitoring device that removes the need to draw blood to
monitor patients has won the 2008 Kerrin Rennie Award for Excellence in Medical
Technology. The award was presented to Masimo Corporation on 24 September at the
Medical Technology Association of Australia (MTAA) dinner in Sydney.

The Radical-7 Pulse CO-Oximeter from Masimo Corporation continuously and
non-invasively measures blood constituents in patients without having to draw blood.
The device uses multiple wavelengths of light in a single, simple to apply sensor.
It can be used reliably in different care settings for example at the patient’s
bedside or during transport.

In addition to its unique use of algorithms to ensure accurate patient monitoring,
the Radical-7 includes a unique technology platform that allows for additional
features to be added as simple software upgrades.

In congratulating the winner, Anne Trimmer, MTAA CEO, said: “Masimo’s Oximeter is an
excellent example of innovation in the medical technology sector. It benefits the
patient, the clinician and the health system.”

The Kerrin Rennie Award for Excellence in Medical Technology – Improving Quality of
Life recognises the innovative and extraordinary contribution of medical technology
in improving health outcomes of Australian patients.

The award dinner was held as part of a two day conference on medical technology from
Wednesday 24 – Thursday 25 September at Star City in Sydney. Companies could enter
products launched in Australia between 1 January 2007 and 1 August 2008 used in the
diagnosis, prevention, treatment or management of disease and disability. Entries
were judged by an independent panel.

The other finalists are:

Ex-Press Shunt - Device Technologies
The Ex-Press miniature glaucoma shunt is an implant used to drain off excess fluid
in the eye and to reduce intraocular pressure. The device creates a permanent
pathway for excess fluid to drain from the eye and maintains a more normal pressure
in the eye. The Ex-Press Shunt is an improved technology that causes less post
operative trauma and fewer adverse events.

HCO 1100 Protein Permeable Membrane – Gambro
The HCO 1100 Protein-Permeable Membrane is designed to improve the treatment of
multiple myeloma patients with acute renal failure by removing larger molecules from
blood particularly serum Free Light Chains (FLC), the protein present at abnormally
high concentrations in this patient group. High levels of FLCs in the blood
circulating through the kidney present a major cause of renal impairment. This new
membrane technology in combination with chemotherapy can prevent the patient from
developing end stage renal disease and having to rely on dialysis for survival.

The Medical Technology Association of Australia (MTAA) is the national peak industry
body representing companies in the medical technology industry. MTAA aims to ensure
the benefits of modern, innovative and reliable medical technology are delivered to
the community for a healthier Australia.

www.mtaa.org.au


Web Site: http://www.mtaa.org.au

Contact Details: Media contact: Marion Demann MTAA 0416 625 678